Ashurst Healthcare Limited 31/03/2022 iXBRL

ASHURST HEALTHCARE LIMITED - Company Information

6 31/03/2022 2022-03-31 false false false false false false false false false false true false false true false false false false false false false 2021-04-01 Sage Accounts Production 21.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 09817750 2021-04-01 2022-03-31 09817750 2022-03-31 09817750 2020-04-01 2021-03-31 09817750 2021-03-31 09817750 core:FurnitureFittingsToolsEquipment 2021-04-01 2022-03-31 09817750 bus:RegisteredOffice 2021-04-01 2022-03-31 09817750 bus:OrdinaryShareClass1 2021-04-01 2022-03-31 09817750 bus:OrdinaryShareClass2 2021-04-01 2022-03-31 09817750 bus:OrdinaryShareClass3 2021-04-01 2022-03-31 09817750 bus:OrdinaryShareClass4 2021-04-01 2022-03-31 09817750 bus:OrdinaryShareClass5 2021-04-01 2022-03-31 09817750 bus:LeadAgentIfApplicable 2021-04-01 2022-03-31 09817750 bus:Director1 2021-04-01 2022-03-31 09817750 bus:Director2 2021-04-01 2022-03-31 09817750 bus:Director3 2021-04-01 2022-03-31 09817750 bus:Director4 2021-04-01 2022-03-31 09817750 bus:Director5 2021-04-01 2022-03-31 09817750 bus:Director6 2021-04-01 2022-03-31 09817750 core:LandBuildings core:OwnedOrFreeholdAssets 2022-03-31 09817750 core:FurnitureFittingsToolsEquipment 2022-03-31 09817750 core:WithinOneYear 2022-03-31 09817750 core:WithinOneYear 2021-03-31 09817750 core:AfterOneYear 2022-03-31 09817750 core:ShareCapital 2022-03-31 09817750 core:ShareCapital 2021-03-31 09817750 core:SharePremium 2022-03-31 09817750 core:RetainedEarningsAccumulatedLosses 2022-03-31 09817750 core:RetainedEarningsAccumulatedLosses 2021-03-31 09817750 bus:OrdinaryShareClass1 core:ShareCapital 2022-03-31 09817750 bus:OrdinaryShareClass1 core:ShareCapital 2021-03-31 09817750 bus:OrdinaryShareClass2 core:ShareCapital 2022-03-31 09817750 bus:OrdinaryShareClass2 core:ShareCapital 2021-03-31 09817750 bus:OrdinaryShareClass3 core:ShareCapital 2021-03-31 09817750 bus:OrdinaryShareClass4 core:ShareCapital 2022-03-31 09817750 bus:OrdinaryShareClass4 core:ShareCapital 2021-03-31 09817750 bus:OrdinaryShareClass5 core:ShareCapital 2022-03-31 09817750 bus:OrdinaryShareClass5 core:ShareCapital 2021-03-31 09817750 core:LandBuildings core:OwnedOrFreeholdAssets 2021-04-01 2022-03-31 09817750 bus:SmallEntities 2021-04-01 2022-03-31 09817750 bus:AuditExemptWithAccountantsReport 2021-04-01 2022-03-31 09817750 bus:FullAccounts 2021-04-01 2022-03-31 09817750 bus:SmallCompaniesRegimeForAccounts 2021-04-01 2022-03-31 09817750 bus:PrivateLimitedCompanyLtd 2021-04-01 2022-03-31 09817750 bus:OrdinaryShareClass3 2020-04-01 2021-03-31 09817750 core:AllAssociates 2021-04-01 2022-03-31

Company registration number: 09817750

Ashurst Healthcare Limited

Unaudited filleted financial statements

31 March 2022

Ashurst Healthcare Limited

Contents

Directors and other information

Accountants report

Statement of financial position

Notes to the financial statements

Ashurst Healthcare Limited

Directors and other information


	Directors	Dr L Grant
		Dr C Bolton
		Dr J Reddington
		Dr P Brettell
		Dr Alan Mortimer
		Mrs S Lowe


	Company number	09817750


	Registered office	Crossens Way Business Park
		Crossens Way
		Southport
		Merseyside
		PR9 9LY


	Business address	The Village Surgery
		12 Elbow Lane
		Formby
		Merseyside
		L37 4AW


	Accountants	Forshaws Accountants Limited
		Crossens Way Business Park
		Crossens Way
		Southport
		Merseyside
		PR9 9LY

Ashurst Healthcare Limited

Chartered accountants report to the board of directors on the preparation of the

unaudited statutory financial statements of Ashurst Healthcare Limited

Year ended 31 March 2022

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Ashurst Healthcare Limited for the year ended 31 March 2022 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance.

This report is made solely to the board of directors of Ashurst Healthcare Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Ashurst Healthcare Limited and state those matters that we have agreed to state to the board of directors of Ashurst Healthcare Limited as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Ashurst Healthcare Limited and its board of directors as a body for our work or for this report.

It is your duty to ensure that Ashurst Healthcare Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Ashurst Healthcare Limited. You consider that Ashurst Healthcare Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Ashurst Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Forshaws Accountants Limited

Chartered Accountants

Crossens Way Business Park

Crossens Way

Southport

Merseyside

PR9 9LY

2 November 2022

Ashurst Healthcare Limited

Statement of financial position

31 March 2022

		2022		2021
	Note	£	£	£	£

Fixed assets
Tangible assets	5	219,563		-
		_______		_______
			219,563		-

Current assets
Debtors	6	89,373		115,641
Cash at bank and in hand		82,393		100,690
		_______		_______
		171,766		216,331
Creditors: amounts falling due
within one year	7	( 66,354)		( 48,255)
		_______		_______
Net current assets			105,412		168,076
			_______		_______
Total assets less current liabilities			324,975		168,076

Creditors: amounts falling due
after more than one year	8		( 106,903)		-
			_______		_______
Net assets			218,072		168,076
			_______		_______

Capital and reserves
Called up share capital	9		600		600
Share premium account			23,900		-
Profit and loss account			193,572		167,476
			_______		_______
Shareholders funds			218,072		168,076
			_______		_______

For the year ending 31 March 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

These financial statements were approved by the board of directors and authorised for issue on 02 November 2022 , and are signed on behalf of the board by:

Dr Alan Mortimer

Director

Company registration number: 09817750

Ashurst Healthcare Limited

Notes to the financial statements

Year ended 31 March 2022

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Crossens Way Business Park, Crossens Way, Southport, Merseyside, PR9 9LY.

The principal activity of the company is that of providing general medical services.

2. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Tangible assets

tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:


Freehold property	-	Stated at cost
Fittings fixtures and equipment	-	15 %	straight line

If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost.Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised in finance costs in profit or loss in the period in which it arises.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 6 (2021: 5 ).

5. Tangible assets

	Freehold property	Fixtures, fittings and equipment	Total
	£	£	£
Cost
At 1 April 2021	-	-	-
Additions	216,730	3,333	220,063
	_______	_______	_______
At 31 March 2022	216,730	3,333	220,063
	_______	_______	_______
Depreciation
At 1 April 2021	-	-	-
Charge for the year	-	500	500
	_______	_______	_______
At 31 March 2022	-	500	500
	_______	_______	_______
Carrying amount
At 31 March 2022	216,730	2,833	219,563
	_______	_______	_______
At 31 March 2021	-	-	-
	_______	_______	_______

6. Debtors

	2022	2021
	£	£
Other debtors	89,373	115,641
	_______	_______

7. Creditors: amounts falling due within one year

	2022	2021
	£	£
Bank loans and overdrafts	15,819	-
Trade creditors	1,627	-
Corporation tax	35,948	45,195
Other creditors	12,960	3,060
	_______	_______
	66,354	48,255
	_______	_______

8. Creditors: amounts falling due after more than one year

	2022	2021
	£	£
Bank loans and overdrafts	106,903	-
	_______	_______

9. Called up share capital

Issued, called up and fully paid

	2022		2021
	No	£	No	£
Ordinary A shares of £ 1.00 each	100	100	100	100
Ordinary B shares of £ 1.00 each	100	100	100	100
Ordinary C shares of £ - each (2021: £ 1.00 )	-	-	100	100
Ordinary D shares of £ 1.00 each	100	100	100	100
Ordinary E shares of £ 1.00 each	100	100	100	100
Ordinary F shares of £ 1.00 each	100	100	100	100
Ordinary G shares of £ 1.00 each	100	100	-	-
	_______	_______	_______	_______
	600	600	600	600
	_______	_______	_______	_______

10. Related party transactions

At 31 March 2021, the company was owed £85,240 (2021 - £112,221) by The Village Surgery in which Drs Grant, Bolton, Brettell, Mortimer, Lin and Susan Lowe are all partners.

11. Controlling party

The company is not under the control of any one individual.